Open main menu
Search Ctrl + K
Sign up for free
Loading...
C4 Therapeutics, Inc.
Watch
Biological Products, (no Diagnostic Substances)
NASDAQ.CCCC
490 Arsenal Way, Suite 120, Watertown, MA, 02472
Categorized
Chronological
Ownership by Owner
Insider Transactions
Institutional Owners
Filings by Form Type
Transcripts
Your Highlights
Search Within Documents
Key Exhibits
Articles & Bylaws
Indentures
Material contracts
Plans of Reorganization
Underwriting Agreements
External Links
Google Finance
SEC EDGAR
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Proxies
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
29 Apr 24
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
29 Apr 24
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
28 Apr 23
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
28 Apr 23
PRE 14A
Preliminary Proxy Statement Not Yet Definitive.
18 Apr 23
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
17 Jun 22
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
12 May 22
Ownership
4
Fawell Stephen
03 Sep 24
3
Fawell Stephen
03 Sep 24
4
Reyno Leonard
11 Jul 24
SC 13G/A
10 Jul 24
4
Anderson Kenneth Carl
02 Jul 24
4
Grogan Donna Roy
02 Jul 24
4
Salter Malcolm
21 Jun 24
News
8-K
Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers, Regulation Fd Disclosure, Financial Statements And Exhibits
03 Sep 24
8-K
Results Of Operations And Financial Condition
01 Aug 24
8-K
Submission Of Matters To A Vote Of Security Holders
21 Jun 24
8-K
Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers, Regulation Fd Disclosure, Financial Statements And Exhibits
10 Jun 24
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
08 May 24
8-K
Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers
08 Mar 24
8-K
Entry Into A Material Definitive Agreement, Regulation Fd Disclosure, Financial Statements And Exhibits
04 Mar 24
Prospectuses and Registrations
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
22 Feb 24
POS AM
Post-effective Amendment To An S-1 Or Other Registration Form.
23 Feb 23
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
23 Feb 23
POSASR
Automatic Shelf Registration Statement Of Securities For Resale.
23 Feb 23
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
24 Feb 22
S-3ASR
Automatic Shelf Registration Statement Of Securities By Well-known Seasoned Issuers.
10 Nov 21
424B4
Prospectus Filed Pursuant To Rule 424(b)(4).
21 Jun 21
Financials
10-Q
Quarterly Filing
01 Aug 24
10-Q
Quarterly Filing
08 May 24
10-K
Fiscal Year 2024
22 Feb 24
10-Q
Quarterly Filing
01 Nov 23
10-Q
Quarterly Filing
08 Aug 23
10-Q
Quarterly Filing
04 May 23
10-K
Fiscal Year 2022
23 Feb 23
Other
ARS
Scanned Paper Annual Report Submission.
30 Apr 24
EFFECT
Notice Of Effectiveness For A Previously Filed Sec Document.
03 May 23
ARS
Scanned Paper Annual Report Submission.
28 Apr 23
EFFECT
Notice Of Effectiveness For A Previously Filed Sec Document.
16 Jun 21
CORRESP
Correspondence With The Sec.
14 Jun 21
CORRESP
Correspondence With The Sec.
14 Jun 21
UPLOAD
Letter From The Sec.
21 May 21